Copper as a potential adjunct therapy for critically ill COVID-19 patients

[1]  A. Duttaroy,et al.  Is copper beneficial for COVID-19 patients? , 2020, Medical Hypotheses.

[2]  Robert J. Mason,et al.  Pathogenesis of COVID-19 from a cell biologic perspective , 2020, European Respiratory Journal.

[3]  K. Jemnitz,et al.  Copper signalling: causes and consequences , 2018, Cell Communication and Signaling.

[4]  Dae Ryong Kang,et al.  Serum Concentrations of Trace Elements Zinc, Copper, Selenium, and Manganese in Critically Ill Patients , 2018, Biological Trace Element Research.

[5]  V. Nielsen,et al.  Effects of cupric chloride on coagulation in human plasma: role of fibrinogen , 2018, Journal of Thrombosis and Thrombolysis.

[6]  T. Kehl-Fie,et al.  Role of Copper Efflux in Pneumococcal Pathogenesis and Resistance to Macrophage-Mediated Immune Clearance , 2015, Infection and Immunity.

[7]  S. Warnes,et al.  Mechanism of Copper Surface Toxicity in Vancomycin-Resistant Enterococci following Wet or Dry Surface Contact , 2011, Applied and Environmental Microbiology.

[8]  J. Kaplan,et al.  Copper Transport in Mammalian Cells: Special Care for a Metal with Special Needs* , 2009, The Journal of Biological Chemistry.

[9]  J. Sarkar,et al.  Unexpected role of ceruloplasmin in intestinal iron absorption. , 2005, Cell metabolism.

[10]  R. Hopkins,et al.  Copper deficiency reduces interleukin-2 (IL-2) production and IL-2 mRNA in human T-lymphocytes. , 1997, The Journal of nutrition.

[11]  S. Lynch,et al.  Effects of a dietary copper deficiency on plasma coagulation factor activities in male and female mice , 1992 .

[12]  J. Caddell.  A hypothesis: the role of magnesium and possibly copper deficiency in the pathogenesis of the adult or acute respiratory distress syndrome (ARDS) as it occurs in infants, children, and adults , 1993 .